Who
Stephen P. Macmillan
Chairman, President and CEO
Company insider
Files Form 4 as: Chairman, President and CEO, Hologic; Director, Illumina; Director, Boston Scientific; Director, Alere; Director and Other, Texas Instruments; President & CEO, Stryker.
In numbers
- Trades disclosed
- 306
- Buys
- 4
- Sells
- 10
- Bought
- $5.0M
- Sold
- $68.1M
- Companies
- 6
- Companies where not an officer
- 4
- First trade
- 7 Feb 2006
- Last trade
- 7 Apr 2026
- Last filed
- 9 Apr 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 7 Apr 2026filed 9 Apr 2026 | HologicMedical Devices | SEC FORM 4 Code D | —1,423,837 | filing |
| 7 Apr 2026filed 9 Apr 2026 | Hologicoption or derivative · Medical Devices | SEC FORM 4 Code D | —106,300 | filing |
| 7 Apr 2026filed 9 Apr 2026 | Hologicoption or derivative · Medical Devices | SEC FORM 4 Code D | —117,829 | filing |
| 7 Apr 2026filed 9 Apr 2026 | Hologicoption or derivative · Medical Devices | SEC FORM 4 Code D | —117,801 | filing |
| 7 Apr 2026filed 9 Apr 2026 | Hologicoption or derivative · Medical Devices | SEC FORM 4 Code A | —190,400 | filing |
| 7 Apr 2026filed 9 Apr 2026 | Hologicoption or derivative · Medical Devices | SEC FORM 4 Code D | —190,400 | filing |
| 7 Apr 2026filed 9 Apr 2026 | HologicMedical Devices | SEC FORM 4 Code D | —1,146,829 | filing |
| 7 Apr 2026filed 9 Apr 2026 | Hologicoption or derivative · Medical Devices | SEC FORM 4 Code D | —160,565 | filing |
| 7 Apr 2026filed 9 Apr 2026 | Hologicoption or derivative | SEC FORM 4 Code D | —160,565 | filing |
| 7 Apr 2026filed 9 Apr 2026 | Hologicoption or derivative | SEC FORM 4 Code D | —159,339 | filing |
| 7 Apr 2026filed 9 Apr 2026 | Hologicoption or derivative | SEC FORM 4 Code D | —768,639 | filing |
| 7 Apr 2026filed 9 Apr 2026 | Hologicoption or derivative | SEC FORM 4 Code D | —151,071 | filing |
| 7 Apr 2026filed 9 Apr 2026 | Hologicoption or derivative | SEC FORM 4 Code D | —152,529 | filing |
| 7 Apr 2026filed 9 Apr 2026 | Hologicoption or derivative | SEC FORM 4 Code D | —123,801 | filing |
| 7 Apr 2026filed 9 Apr 2026 | Hologicoption or derivative | SEC FORM 4 Code D | —118,877 | filing |
| 7 Apr 2026filed 9 Apr 2026 | Hologicoption or derivative | SEC FORM 4 Code D | —106,300 | filing |
| 7 Apr 2026filed 9 Apr 2026 | Hologicoption or derivative | SEC FORM 4 Code D | —117,829 | filing |
| 7 Apr 2026filed 9 Apr 2026 | Hologicoption or derivative | SEC FORM 4 Code D | —117,801 | filing |
| 7 Apr 2026filed 9 Apr 2026 | Hologicoption or derivative | SEC FORM 4 Code A | —190,400 | filing |
| 7 Apr 2026filed 9 Apr 2026 | Hologicoption or derivative | SEC FORM 4 Code D | —190,400 | filing |
News
No headline names them, or the companies they trade most, lately.